| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 8974 | 2020 |
| Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 E Nichols, JD Steinmetz, SE Vollset, K Fukutaki, J Chalek, F Abd-Allah, ... The Lancet Public Health 7 (2), e105-e125, 2022 | 3021 | 2022 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 2495 | 2021 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1488 | 2022 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 731 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 645 | 2020 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 430 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 410 | 2024 |
| Valproic acid and epilepsy: from molecular mechanisms to clinical evidences M Romoli, P Mazzocchetti, R D'Alonzo, S Siliquini, VE Rinaldi, A Verrotti, ... Current neuropharmacology 17 (10), 926-946, 2019 | 326 | 2019 |
| Levodopa in Parkinson's disease: current status and future developments N Tambasco, M Romoli, P Calabresi Current neuropharmacology 16 (8), 1239-1252, 2018 | 281 | 2018 |
| Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: a systematic review and meta‐analysis T Baldini, GM Asioli, M Romoli, M Carvalho Dias, EC Schulte, L Hauer, ... European journal of neurology 28 (10), 3478-3490, 2021 | 185 | 2021 |
| The impact of SARS‐CoV‐2 on stroke epidemiology and care: a meta‐analysis AH Katsanos, L Palaiodimou, R Zand, S Yaghi, H Kamel, BB Navi, G Turc, ... Annals of neurology 89 (2), 380-388, 2021 | 160 | 2021 |
| A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details M Romoli, I Jelcic, R Bernard‐Valnet, D García Azorín, L Mancinelli, ... European journal of neurology 27 (9), 1712-1726, 2020 | 129* | 2020 |
| Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 GBD 2019 Collaborators, E Nichols, F Abd‐Allah, A Abdoli, AE Abosetugn, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021 | 123 | 2021 |
| Amyloid-β: a potential link between epilepsy and cognitive decline M Romoli, A Sen, L Parnetti, P Calabresi, C Costa Nature Reviews Neurology 17 (8), 469-485, 2021 | 106 | 2021 |
| Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology C Costa, M Romoli, C Liguori, L Farotti, P Eusebi, C Bedetti, S Siliquini, ... Neurobiology of Aging 73, 61-67, 2019 | 103 | 2019 |
| Mothership versus drip-and-ship model for mechanical thrombectomy in acute stroke: a systematic review and meta-analysis for clinical and radiological outcomes M Romoli, M Paciaroni, G Tsivgoulis, EC Agostoni, S Vidale Journal of stroke 22 (3), 317, 2020 | 88 | 2020 |
| Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort P Eusebi, M Romoli, FP Paoletti, N Tambasco, P Calabresi, L Parnetti NPJ Parkinson's disease 4 (1), 33, 2018 | 80 | 2018 |
| Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants TR Meinel, D Wilson, H Gensicke, JF Scheitz, P Ringleb, I Goganau, ... JAMA neurology 80 (3), 233-243, 2023 | 79 | 2023 |
| Triptans and CGRP blockade–impact on the cranial vasculature S Benemei, F Cortese, A Labastida-Ramírez, F Marchese, L Pellesi, ... The journal of headache and pain 18, 1-7, 2017 | 75 | 2017 |